Treatment of Thyrotoxicosis

Initial Management and Symptom Control

The American College of Cardiology recommends beta blockers as the preferred initial therapy for controlling ventricular rate and managing hyperadrenergic symptoms in patients with thyrotoxicosis, particularly important in thyroid storm and when catecholamine state is elevated 1, 2, 3, 4, 5
Non-selective beta blockers with alpha receptor-blocking capacity are preferred for symptomatic patients with thyrotoxicosis 6, 7, 8
When beta blockers are contraindicated, the American College of Cardiology recommends nondihydropyridine calcium channel antagonists (diltiazem or verapamil) as alternatives for patients with thyrotoxicosis 1, 2, 3, 4, 5
Intravenous beta blockers may be required in severe cases of thyrotoxicosis, with high doses sometimes necessary 3, 4

The American College of Cardiology recommends that antithyroid drugs and cardioversion often fail while thyrotoxicosis persists; efforts to restore normal sinus rhythm should be deferred until euthyroid state is achieved in patients with hyperthyroidism 1, 2, 5
For thyroiditis-induced thyrotoxicosis, beta blockers are recommended for symptomatic relief only, and antithyroid drugs are not effective 6, 7, 8, 9
Thyroiditis typically resolves within 1 month, followed by hypothyroidism requiring replacement therapy, and monitoring of thyroid function every 2-3 weeks is recommended 6, 7, 8, 9

The American College of Cardiology recommends that anticoagulation decisions should be guided by CHA2DS2-VASc risk factors, not thyrotoxicosis alone, in patients with atrial fibrillation 1, 2, 5
Evidence suggests embolic risk is not necessarily increased independent of other stroke risk factors in patients with thyrotoxicosis 1, 2, 5
Antithrombotic therapy is recommended based on presence of other stroke risk factors in patients with thyrotoxicosis 3, 4
For severe or life-threatening cases of thyrotoxicosis, holding immunotherapy, considering hospitalization, and endocrine consultation are recommended 9
Additional therapies may include steroids, SSKI, or thionamides (methimazole or propylthiouracil), and possible surgery for severe cases of thyrotoxicosis 9

The American College of Cardiology recommends that rhythm control with antiarrhythmic drugs or cardioversion should not be attempted until euthyroid state is achieved in patients with thyrotoxicosis 1, 2, 3, 4, 5
Antithyroid drugs should not be used for thyroiditis—they are ineffective and unnecessary 6, 7, 8
The need for thyroid hormone replacement should not be overlooked when thyroiditis transitions to hypothyroidism 6, 7, 8